Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin (Q33317058)

25 July 2017

title

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin (English)

1 reference

inflammatory breast cancer

25 July 2017

0 references

1 reference

1 reference

Emmanuelle Charafe-Jauffret

inferred from title

author

4

object named as

Emmanuelle Charafe-Jauffret

0 references

Jocelyne Jacquemier

11

object named as

Jocelyne Jacquemier

0 references

Daniel Birnbaum

10

object named as

Daniel Birnbaum

1 reference

25 July 2017

Azza Ben Hamida

1

1 reference

25 July 2017

Intidhar S Labidi

2

1 reference

25 July 2017

Karima Mrad

3

1 reference

25 July 2017

Saïda Ben Arab

5

1 reference

25 July 2017

Benjamin Esterni

6

1 reference

25 July 2017

Luc Xerri

7

1 reference

25 July 2017

Patrice Viens

8

1 reference

25 July 2017

François Bertucci

9

1 reference

25 July 2017

language of work or name

English

0 references

publication date

29 January 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

8

1 reference

25 July 2017

page(s)

28

1 reference

describes a project that uses

25 July 2017

1 reference

P-cadherin expression in breast cancer: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Moesin expression is a marker of basal breast carcinomas.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Inflammatory breast cancers in Tunisia and France show similar immunophenotypes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Deconstructing the molecular portrait of basal-like breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Increasing evidence for a human breast carcinoma virus with geographic differences

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Basal and luminal breast cancers: basic or luminous? (review).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Update on the management of inflammatory breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Molecular portraits of human breast tumours

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Aberrant P-cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Rapidly progressing breast cancer (poussée évolutive) in Tunisia: studies on delayed hypersensitivity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-28

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-28

Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-28

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-28

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267802

High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer

31 October 2018

1 reference

12 December 2020

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

1 reference

12 December 2020

Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function

1 reference

12 December 2020

Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program

1 reference

12 December 2020

Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis

1 reference

12 December 2020

[European recommendations for quality assurance in the setting of mammographic screening for breast cancer. Report of pathologists of the working group "Breast Cancer Screening" of the European Union]

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-28

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference